Ollin Shows Superior Results vs Vabysmo in Eye Disease Study
08 Jan 2026 //
BUSINESSWIRE
Ollin Eyes Phase 3 After Topping Vabysmo In Early-Stage Trial
08 Jan 2026 //
FIERCE BIOTECH
Ollin Biosciences Presents at 44th J.P. Morgan Healthcare Conf
18 Dec 2025 //
BUSINESSWIRE
Addition Debuts $100M Fund for Rare Disease One-Time Therapies
17 Dec 2025 //
BIOSPACE

Market Place
Sourcing Support